Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
Abstract Paraoxonase 1 (PON1) is known for preventing atherosclerosis through lipid-modifying features, antioxidant activity, anti-inflammatory, anti-apoptosis, anti-thrombosis, and anti-adhesion properties. Uremic patients requiring haemodialysis (HD) are especially prone to atherosclerosis and its...
Guardado en:
Autores principales: | Alicja E. Grzegorzewska, Paulina Adamska, Ewa Iwańczyk-Skalska, Kamila Ostromecka, Leszek Niepolski, Wojciech Marcinkowski, Adrianna Mostowska, Wojciech Warchoł, Czesław Żaba, Paweł P. Jagodziński |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9701bf56024d4c1592c2479aeb3ad4fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Paraoxonase 1 gene variants concerning cardiovascular mortality in conventional cigarette smokers and non-smokers treated with hemodialysis
por: Alicja E. Grzegorzewska, et al.
Publicado: (2021) -
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Anandita Agarwala, et al.
Publicado: (2020) -
Anthocyanin on platelet function in people with dyslipidaemia
por: Ayodele A. Ogunleye
Publicado: (2021) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020) -
Paraoxonase-1 and Early-Life Environmental Exposures
por: Judit Marsillach, et al.
Publicado: (2016)